Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Hyperfine Inc

HYPR
0,9199
0,0309 (3,48%)
16 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/11/202422:05BWHyperfine, Inc. to Participate in Upcoming Investor..
12/11/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:15EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEHyperfine, Inc. Reports Third Quarter 2024 Financial Results
07/11/202415:00BWHyperfine Announces European Launch with CE Approval
31/10/202414:00BWHyperfine Announces Alzheimer’s Research with Promising..
24/10/202422:05BWHyperfine, Inc. to Announce Third Quarter 2024 Financial..
01/10/202415:00BWHyperfine Swoop® Portable MR Imaging® System Utilized in..
23/9/202415:44BWHyperfine Announces Promising Interim Findings on the Value..
11/9/202414:05BWResearchers to Monitor Astronaut Brain Health Using Images..
28/8/202422:05BWHyperfine, Inc. to Participate in Upcoming Investor..
16/8/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:11EDGAR2Form 8-K - Current report
08/8/202422:05GLOBEHyperfine, Inc. Reports Record Quarterly Revenue and Raises..
30/7/202415:00BWHyperfine Announces Presentation of Initial Data from..
24/7/202422:15EDGAR2Form 8-K - Current report
17/7/202415:00BWHyperfine Announces FDA Clearance of Software Update That..
15/7/202415:00BWPortable MRI as a Tissue Clock for Acute Ischemic Stroke:..
11/7/202422:05BWHyperfine, Inc. to Announce Second Quarter 2024 Financial..
10/7/202415:00BWHyperfine Expands European Market Reach with Additional..
25/6/202415:00BWClinical Research Using Swoop® System for Alzheimer's..
12/6/202422:04EDGAR2Form 8-K - Current report
03/6/202422:05BWHyperfine, Inc. to Host Analyst and Investor Education..
31/5/202422:06EDGAR2Form 8-K - Current report
28/5/202415:00BWHyperfine, Inc. Continues Global Market Expansion by..
22/5/202422:05BWHyperfine, Inc. to Present at the Jefferies Global..
22/5/202415:00BWHyperfine, Inc. Celebrates ASNR 2024
16/5/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:13EDGAR2Form 8-K - Current report
13/5/202422:05GLOBEHyperfine, Inc. Reports First Quarter 2024 Financial Results
10/5/202415:00BWHyperfine, Inc. to Expand Global Market Reach with..
29/4/202422:05BWHyperfine, Inc. to Announce First Quarter 2024 Financial..
23/4/202415:00BWHyperfine, Inc. Takes the Stage at ISMRM with Seventeen..
17/4/202415:00BWLeading Institutions Enroll First Alzheimer’s Patients..
21/3/202421:05GLOBEHyperfine, Inc. Reports Fourth Quarter and Full Year 2023..
21/3/202412:26IHMARKETNEWSU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs..
12/3/202414:00BWHyperfine, Inc. Collaborates with King’s College London to..
07/3/202422:30BWHyperfine, Inc. to Announce Fourth Quarter and Full Year..
28/2/202422:30BWHyperfine, Inc. to Present at the Oppenheimer 34th Annual..
21/2/202415:00BWHyperfine, Inc. Announces Collaboration with Athletic Heart..
16/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202414:00BWHyperfine, Inc. Celebrates Breadth of Swoop® System Data..
09/1/202415:00BWHyperfine, Inc. Launches AI-powered Brain Imaging Software..
24/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/11/202300:20EDGAR2Form 3/A - Initial statement of beneficial ownership of..
20/11/202315:00BWHyperfine, Inc. Announces Presentations on Clinical..
18/11/202301:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,85 Min: 0,82 Max: 0,8854
Chiusura: 0,889

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network